83 related articles for article (PubMed ID: 23717463)
1. Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.
Rotman Y; Noureddin M; Feld JJ; Guedj J; Witthaus M; Han H; Park YJ; Park SH; Heller T; Ghany MG; Doo E; Koh C; Abdalla A; Gara N; Sarkar S; Thomas E; Ahlenstiel G; Edlich B; Titerence R; Hogdal L; Rehermann B; Dahari H; Perelson AS; Hoofnagle JH; Liang TJ
Gut; 2014 Jan; 63(1):161-9. PubMed ID: 23396509
[TBL] [Abstract][Full Text] [Related]
2. Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review.
Oka R; Hiroi N; Shigemitsu R; Sue M; Oshima Y; Yoshida-Hiroi M
Clin Med Insights Endocrinol Diabetes; 2011; 4():39-45. PubMed ID: 22879793
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-VDR Novel Anti-Inflammatory Molecules-New Insights into Their Effects on Liver Diseases.
Aggeletopoulou I; Thomopoulos K; Mouzaki A; Triantos C
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955597
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic M; Nikolova D; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011564. PubMed ID: 34431511
[TBL] [Abstract][Full Text] [Related]
5. Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection.
Chen HW; Chiu YL; Hsieh TY; Chen PJ; Huang TY; Lin HH; Shih YL; Lin JC
J Inflamm Res; 2020; 13():1207-1218. PubMed ID: 33402842
[TBL] [Abstract][Full Text] [Related]
6. The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection.
Kondo Y; Kogure T; Ninomiya M; Fukuda R; Monma N; Ikeo K; Tanaka Y
Sci Rep; 2019 Sep; 9(1):13393. PubMed ID: 31527804
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
[TBL] [Abstract][Full Text] [Related]
8. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients.
Belle A; Gizard E; Conroy G; Lopez A; Bouvier-Alias M; Rouanet S; Peyrin-Biroulet L; Pawlotsky JM; Bronowicki JP
United European Gastroenterol J; 2017 Feb; 5(1):69-75. PubMed ID: 28405324
[TBL] [Abstract][Full Text] [Related]
9. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
Komolmit P; Charoensuk K; Thanapirom K; Suksawatamnuay S; Thaimai P; Chirathaworn C; Poovorawan Y
PLoS One; 2017; 12(4):e0174608. PubMed ID: 28376103
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment.
Kondo Y
World J Gastroenterol; 2017 Feb; 23(8):1325-1327. PubMed ID: 28293078
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in vitamin D receptor were associated with the outcomes of hepatitis C virus infection among Chinese population.
Wu MP; Zhang JW; Huang P; Han YP; Zhang Y; Peng ZH; Wang J; Zhu P; Su J; Yu RB; Li J; Yue M
J Hum Genet; 2016 Feb; 61(2):129-35. PubMed ID: 26446365
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.
Refaat B; El-Shemi AG; Ashshi A; Azhar E
Int J Clin Exp Med; 2015; 8(7):10284-303. PubMed ID: 26379820
[TBL] [Abstract][Full Text] [Related]
13. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.
Atsukawa M; Tsubota A; Shimada N; Yoshizawa K; Abe H; Asano T; Ohkubo Y; Araki M; Ikegami T; Kondo C; Itokawa N; Nakagawa A; Arai T; Matsushita Y; Nakatsuka K; Furihata T; Chuganji Y; Matsuzaki Y; Aizawa Y; Iwakiri K
BMC Infect Dis; 2015 Aug; 15():344. PubMed ID: 26286329
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder.
Mansueto P; Seidita A; Vitale G; Gangemi S; Iaria C; Cascio A
Biomed Res Int; 2015; 2015():735615. PubMed ID: 26000302
[TBL] [Abstract][Full Text] [Related]
15. Significant biomarkers for the management of hepatocellular carcinoma.
Kondo Y; Kimura O; Shimosegawa T
Clin J Gastroenterol; 2015 Jun; 8(3):109-15. PubMed ID: 25855582
[TBL] [Abstract][Full Text] [Related]
16. 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial.
Kondo Y; Kato T; Kimura O; Iwata T; Ninomiya M; Kakazu E; Miura M; Akahane T; Miyazaki Y; Kobayashi T; Ishii M; Kisara N; Sasaki K; Nakayama H; Igarashi T; Obara N; Ueno Y; Morosawa T; Shimosegawa T
PLoS One; 2013; 8(5):e63672. PubMed ID: 23717463
[TBL] [Abstract][Full Text] [Related]
17. Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.
Kondo Y; Ueno Y; Ninomiya M; Tamai K; Tanaka Y; Inoue J; Kakazu E; Kobayashi K; Kimura O; Miura M; Yamamoto T; Kobayashi T; Igarashi T; Shimosegawa T
J Gastroenterol; 2012 Dec; 47(12):1323-35. PubMed ID: 22588246
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
Di Bisceglie AM; Janczweska-Kazek E; Habersetzer F; Mazur W; Stanciu C; Carreno V; Tanasescu C; Flisiak R; Romero-Gomez M; Fich A; Bataille V; Toh ML; Hennequi M; Zerr P; Honnet G; Inchauspé G; Agathon D; Limacher JM; Wedemeyer H
Gastroenterology; 2014 Jul; 147(1):119-131.e3. PubMed ID: 24657484
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
Wang T; Blatt LM; Seiwert SD
J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
